-
The study has found a link between step count and health in heart failure patients. WEMU’s Victoria Smith reports.
-
A drug to treat Alzheimer’s disease was approved by the Food & Drug Administration. While it is not a cure, researchers at the University of Michigan are optimistic about what this could mean for patients and their loved ones. WEMU’s Josh Hakala reports.
-
A virus with COVID-like symptoms is being noticed by a Washtenaw County hospital. WEMU’s Victoria Smith reports.
-
These ozone action days have led to a minimal uptick in calls to lung doctors in Washtenaw County. But as WEMU’s Cathy Shafran reports, local respiratory experts say it’s pretty hard to distinguish lately between allergy and ozone cases.
-
The future is going to be dropped off at your doorstep in 2024. Michigan Medicine is planning to begin using drone service for patients needing medications delivered. The air over Washtenaw County will be busier, but more fossil-fuel delivery vehicles will be taken off the road. What are the environmental implications? We'll find out together when Dana Habers, the Chief Operating Officer of Pharmacy Services and Chief Innovation Officer for University of Michigan Health, joins WEMU's David Fair for this week's "Issues of the Environment".
-
Michigan Medicine and Sparrow Health System are now under one umbrella. As we hear from WEMU’s Cathy Shafran, the merger received regulatory approval and went into effect on April 1st.
-
The University of Michigan is updating its COVID-19 vaccination policy. We get more from WEMU's Taylor Pinson.
-
Michigan Medicine unveiled a new mobile mammography unit in Ypsilanti on Wednesday. WEMU's Josh Hakala reports.
-
The U.S. Food and Drug Administration, this month, granted accelerated approval to an Alzheimer’s drug that might slow the acceleration of memory loss for early-stage Alzheimer’s patients. But neurologist Dr. Judy Heidebrink at Michigan Alzheimer’s Disease Center at University of Michigan Health is looking at this drug with caution. WEMU’s Cathy Shafran brings us an in-depth discussion with Dr. Heidebrink about local hopes for the drug Lecanemab.
-
With some ownership changes, the western part of downtown Ypsilanti is beginning the process of getting a makeover. WEMU’s Josh Hakala reports.